Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2021-04-14 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LAMPAUL-PLOUARZEL (29810), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LAMPAUL PLOUARZEL : revenue, balance sheet and financial ratios
PHARMACIE DE LAMPAUL PLOUARZEL is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LAMPAUL-PLOUARZEL (29810),
this company of category PME
shows in 2024 a net income positive of 45 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LAMPAUL PLOUARZEL (SIREN 898229208)
Indicator
2024
2023
2022
Revenue
N/C
N/C
N/C
Net income
45 423 €
79 960 €
64 438 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE LAMPAUL PLOUARZEL generates positive net income of 45 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2024: 64 k€ -> 45 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
45 423 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 294%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
294.261%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
21.624%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LAMPAUL PLOUARZEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
2024
Debt ratio
560.036
247.678
294.261
Financial autonomy
12.581
21.795
21.624
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
294.262024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE DE LAMPAUL PLOU... (294.26) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
21.62%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of PHARMACIE DE LAMPAUL PLOU... (21.6%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 188.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
188.807
Liquidity indicators evolution PHARMACIE DE LAMPAUL PLOUARZEL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2022
2023
2024
Liquidity ratio
184.299
143.419
188.807
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
188.812024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+9 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE LAMPAUL PLOU... (188.81) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE LAMPAUL PLOUARZEL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LAMPAUL PLOUARZEL is estimated at
634 138 €
(range 441 604€ - 948 707€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
441k€634k€948k€
634 138 €Range: 441 604€ - 948 707€
NAF 5 année 2024
Valuation method used
Net Income Multiple
45 423 €
×
14.0x
=634 139 €
Range: 441 604€ - 948 708€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LAMPAUL PLOUARZEL with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LAMPAUL PLOUARZEL
What is the revenue of PHARMACIE DE LAMPAUL PLOUARZEL ?
The revenue of PHARMACIE DE LAMPAUL PLOUARZEL is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE LAMPAUL PLOUARZEL profitable?
Yes, PHARMACIE DE LAMPAUL PLOUARZEL generated a net profit of 45 k€ in 2024.
Where is the headquarters of PHARMACIE DE LAMPAUL PLOUARZEL ?
The headquarters of PHARMACIE DE LAMPAUL PLOUARZEL is located in LAMPAUL-PLOUARZEL (29810), in the department Finistere.
Where to find the tax return of PHARMACIE DE LAMPAUL PLOUARZEL ?
The tax return of PHARMACIE DE LAMPAUL PLOUARZEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LAMPAUL PLOUARZEL operate?
PHARMACIE DE LAMPAUL PLOUARZEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart